Cited by 283Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.

Astrocytes in the initiation and progression of epilepsy

Open access

Abstract

Epilepsy affects ~65 million people worldwide. First-line treatment options include >20 antiseizure medications, but seizure control is not achieved in approximately one-third of patients. Antiseizure medications act primarily on neurons and can provide symptomatic control of seizures, but do not alter the onset and progression of epilepsy and can cause serious adverse effects. Therefore, medications with new cellular and molecular targets and mechanisms of action are needed. Accumulating evidence indicates that astrocytes are crucial to the pathophysiological mechanisms of epilepsy, raising the possibility that these cells could be novel therapeutic targets. In this Review, we discuss how dysregulation of key astrocyte functions - gliotransmission, cell metabolism and immune function - contribute to the development and progression of hyperexcitability in epilepsy. We consider strategies to mitigate astrocyte dysfunction in each of these areas, and provide an overview of how astrocyte activation states can be monitored in vivo not only to assess their contribution to disease but also to identify markers of disease processes and treatment effects. Improved understanding of the roles of astrocytes in epilepsy has the potential to lead to novel therapies to prevent the initiation and progression of epilepsy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41582-022-00727-5

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 207 references

Cited by

Sorted by citations

Metadata

Authors
Vezzani, A., Ravizza, T., Bedner, P., Aronica, E., Steinhäuser, C., & Boison, D.
Affiliations
  • Mario Negri Institute for Pharmacological Research (IT)
  • University of Bonn (DE)
  • Amsterdam Neuroscience (NL)
  • Rutgers, The State University of New Jersey (US)
Corresponding author
Vezzani, Annamaria
Venue
Nature Reviews Neurology
Published
2022-10-24
Volume
18
Issue
12
Pages
707-722
ISSN
  • 1759-4758 (ISSN-L)
  • 1759-4766
OpenAlex
W4307338781
Cited by
272
References
207
Citations by year
2026: 82 · 2025: 96 · 2024: 53 · 2023: 41
FWCI
8.65
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Pure Amsterdam UMC (acceptedVersion, other-oa)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
Funders
  • Citizens United for Research in Epilepsy (NS065957, NS103740)
  • ZonMw
  • Bundesministerium für Bildung und Forschung (16GW0182, 01DN20001 CONNEX, 01DN20001, 16GW0182 CONNEXIN)
  • Epilepsy Society
  • National Institutes of Health (H2020, NS127846)
  • Horizon 2020 Framework Programme (H2020-MSCA, 952455, 722053, H2020-MSCA-ITN)
  • National Institute of Neurological Disorders and Stroke (R01NS061844, R01NS103740, R01NS065957, R01NS127846)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
astrocytes, epilepsy, epileptogenesis, hyperexcitability, gliotransmission, astrocyte metabolism, astrocyte activation, antiepileptic drugs, novel therapeutic targets
MeSH terms
Astrocytes, Epilepsy, Humans, Neurons, Seizures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review